To include your compound in the COVID-19 Resource Center, submit it here.

Genmab, Medarex, Oxford GlycoSciences deal

Under a 2000 agreement, the companies will

Read the full 73 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE